PRESS RELEASE published on 10/16/2025 at 07:00, 1 year ago Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months of 2025. Group sales revenue up 7.5% with double-digit increase in EBITDA. Management specifies full-year guidance for the Group and divisions EBITDA Sartorius Profitable Growth Sales Revenue Full-year Guidance
BRIEF published on 07/22/2025 at 07:05, 1 year 3 months ago Sartorius annonce une forte croissance au premier semestre 2025 Sartorius AG Sciences De La Vie Augmentation De L'EBITDA Premier Semestre 2025 Croissance Des Bioprocédés
BRIEF published on 07/22/2025 at 07:05, 1 year 3 months ago Sartorius Reports Strong Growth in First Half of 2025 Life Sciences Sartorius AG EBITDA Increase First Half 2025 Bioprocess Growth
PRESS RELEASE published on 07/22/2025 at 07:00, 1 year 3 months ago Sartorius continues growth course; earnings rise at a significantly overproportionate rate Sartorius AG reports continued growth with significant increase in earnings for the first half of 2025. Group's sales revenue up 6.1%. CEO confirms guidance for the full year 2025 Sales Revenue Growth Earnings Sartorius AG Guidance
BRIEF published on 07/01/2025 at 17:35, 1 year 4 months ago Sartorius finalise l'acquisition de MatTek Acquisition Sartorius Développement De Médicaments MatTek Technologie Cellulaire
BRIEF published on 07/01/2025 at 17:35, 1 year 4 months ago Sartorius Finalizes Acquisition of MatTek Acquisition Sartorius Drug Development MatTek Cell Technology
PRESS RELEASE published on 07/01/2025 at 17:30, 1 year 4 months ago Sartorius completes acquisition of MatTek Sartorius completes acquisition of MatTek from BICO Group AB, expanding its cell technology portfolio and creating synergies with existing solutions for drug development Acquisition Sartorius Drug Development MatTek Cell Technology
BRIEF published on 05/02/2025 at 09:27, 1 year 6 months ago Sartorius prolonge le mandat d'Alexandra Gatzemeyer au conseil d'administration Sartorius AG Industrie Biopharmaceutique Conseil Exécutif Alexandra Gatzemeyer Produits De Laboratoire
BRIEF published on 05/02/2025 at 09:27, 1 year 6 months ago Sartorius Extends Executive Board Tenure for Alexandra Gatzemeyer Executive Board Sartorius AG Biopharmaceutical Industry Alexandra Gatzemeyer Lab Products
PRESS RELEASE published on 05/02/2025 at 09:22, 1 year 6 months ago Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer Sartorius AG extends Dr. Alexandra Gatzemeyer's Executive Board appointment until 2031, responsible for Lab Products & Services Division Executive Board Sartorius AG Appointment Extension Alexandra Gatzemeyer Lab Products & Services Division
Published on 11/06/2026 at 22:15, 1 day 19 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 4 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 4 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 4 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 5 hours 16 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 7 hours 11 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 3 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 21 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 21 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:06, 1 day 22 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 22 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 22 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 22 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
